Dong Sung Bio Pharm.Co.,Ltd.
002210.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$117.52B
Close$
Share Statistics
| Market cap | $117.52 Billion |
|---|---|
| Enterprise Value | $118.65 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1125.56 |
| Beta | -0.36 |
| Outstanding Shares | 94,164,000 |
Return
| Return on Equity | -13.17% |
|---|---|
| Return on Assets | -7.21% |
| Return on Invested Capital | -8.96% |
Valuation & Multiples
| P/E Ratio | -4.38 |
|---|---|
| PEG | 6.38 |
| Price to Sales | 1.43 |
| Price to Book Ratio | 1.34 |
| Enterprise Value to Revenue | 1.45 |
| Enterprise Value to EBIT | -13.99 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.44 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Dong Sung Bio Pharm.Co.,Ltd.
307 employees
CEO: Won-gyun Na Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-coun...